Filgrastim Completed Phase 3 Trials for Neoplasms, Breast / Chemotherapy-Induced Febrile Neutropenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02467868Efficacy and Safety Study With MYL-1401H and Neulasta